The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines

Once Covid-19 vaccines become available, 5–10 billion vaccine doses should be globally distributed, stored and administered. In this commentary, we discuss how this enormous challenge could be addressed for viral vector-based Covid-19 vaccines by learning from the wealth of formulation development e...

Descripción completa

Detalles Bibliográficos
Autores principales: Crommelin, Daan J.A., Volkin, David B., Hoogendoorn, Karin H., Lubiniecki, Anthony S., Jiskoot, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Pharmacists Association®. Published by Elsevier Inc. 2021
Materias:
Special Topic Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682479/
https://www.ncbi.nlm.nih.gov/pubmed/33242452
http://dx.doi.org/10.1016/j.xphs.2020.11.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682479/
https://www.ncbi.nlm.nih.gov/pubmed/33242452
http://dx.doi.org/10.1016/j.xphs.2020.11.015

Ejemplares similares